UPDATE: Goldman Sachs Assumes Arcutis Biotherapeutics Inc. (ARQT) at Buy
Tweet Send to a Friend
(Updated - March 17, 2022 6:04 AM EDT)
Goldman Sachs analyst Chris Shibutani assumes coverage on Arcutis Biotherapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani assumes coverage on Arcutis Biotherapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
